One year of qualification
Audited Supplier
In This Store
Category:Intermediates
Product Name:Exemestane
CAS No.:107868-30-4
Standard:In-house Standards
Price(USD):Interview
Company:Hanways Chempharm Co.,Limited
Grade: Pharmaceutical Grade
Factory Location: Wuhan
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Brief Description
|
Product name |
Exemestane |
|
Synonyms |
Exemestan; 6-Methylenandrosta-1,4-diene-3,17-dione; 10,13-Dimethyl-6-methylidene-7,8,9,10,11,12,13,14,15,16-decahydrocyclopenta[a]phenanthrene-; 6-methylideneandrosta-1,4-diene-3,17-dione; (8ξ,9ξ,14ξ)-6-methylideneandrosta-1,4-diene-3,17-dione; Exemestane(Aromasin); Exemestone |
|
MOQ |
25KG |
|
CAS No. |
107868-30-4 |
|
Appearance |
An almost white powder |
|
Molecular Formula |
C20H24O2 |
|
Molecular Weight |
296.4034 |
|
Assay |
99% |
|
Application |
Pharma grade or research purpose |
|
Packing |
As per your request |
|
Storage |
Preserve in tight, light-resistant containers in a cool place |
|
Remarks |
NA |
|
Custom synthesis |
Available |
|
Supply Ability |
10000kg/month |
Medical use
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy. US FDA approval was in October 2005.
Exemestane is also indicated for the treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
